Literature DB >> 10469673

Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction.

E Gurfinkel1, B M Scirica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10469673      PMCID： PMC1766502          DOI： 10.1136/hrt.82.2008.i15

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

Review 1.  The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.

Authors:  C P Cannon; E Braunwald; C H McCabe; E M Antman
Journal:  J Interv Cardiol       Date:  1995-04       Impact factor: 2.279

2.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

Authors:  M Cohen; C Demers; E P Gurfinkel; A G Turpie; G J Fromell; S Goodman; A Langer; R M Califf; K A Fox; J Premmereur; F Bigonzi
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

Review 3.  Pharmacology of the low-molecular-weight heparins.

Authors:  J Fareed; D A Hoppensteadt
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

4.  Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1997-06       Impact factor: 24.094

5.  Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

Authors:  W Klein; A Buchwald; S E Hillis; S Monrad; G Sanz; A G Turpie; J van der Meer; E Olaisson; S Undeland; K Ludwig
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

6.  Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.

Authors:  P A Merlini; K A Bauer; L Oltrona; D Ardissino; M Cattaneo; C Belli; P M Mannucci; R D Rosenberg
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

7.  Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.

Authors:  E P Gurfinkel; E J Manos; R I Mejaíl; M A Cerdá; E A Duronto; C N García; A M Daroca; B Mautner
Journal:  J Am Coll Cardiol       Date:  1995-08       Impact factor: 24.094

8.  Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina.

Authors:  E Gurfinkel; R Altman; A Scazziota; J Rouvier; B Mautner
Journal:  Br Heart J       Date:  1994-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.